Renaissance Technologies’s Predictive Oncology POAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-24,676
| Closed | -$25.7K | – | 3803 |
|
|
2024
Q2 | $25.7K | Buy |
24,676
+7,500
| +44% | +$7.8K | ﹤0.01% | 3359 |
|
|
2024
Q1 | $44K | Buy |
17,176
+3,000
| +21% | +$7.69K | ﹤0.01% | 3502 |
|
|
2023
Q4 | $47K | Sell |
14,176
-2,700
| -16% | -$8.95K | ﹤0.01% | 3468 |
|
|
2023
Q3 | $54K | Sell |
16,876
-2,000
| -11% | -$6.4K | ﹤0.01% | 3390 |
|
|
2023
Q2 | $92K | Buy |
18,876
+8,560
| +83% | +$41.7K | ﹤0.01% | 3497 |
|
|
2023
Q1 | $67K | Sell |
10,316
-4,820
| -32% | -$31.3K | ﹤0.01% | 3593 |
|
|
2022
Q4 | $93K | Buy |
15,136
+3,213
| +27% | +$19.7K | ﹤0.01% | 3644 |
|
|
2022
Q3 | $86K | Sell |
11,923
-8,332
| -41% | -$60.1K | ﹤0.01% | 3641 |
|
|
2022
Q2 | $166K | Buy |
20,255
+19,500
| +2,583% | +$160K | ﹤0.01% | 3713 |
|
|
2022
Q1 | $15K | Sell |
755
-11,006
| -94% | -$219K | ﹤0.01% | 4014 |
|
|
2021
Q4 | $224K | Buy |
+11,761
| New | +$224K | ﹤0.01% | 3470 |
|
|
2021
Q2 | – | Sell |
-29,663
| Closed | -$718K | – | 3708 |
|
|
2021
Q1 | $718K | Buy |
+29,663
| New | +$718K | ﹤0.01% | 2758 |
|
|
2020
Q3 | – | Sell |
-9,091
| Closed | -$298K | – | 3613 |
|
|
2020
Q2 | $298K | Buy |
+9,091
| New | +$298K | ﹤0.01% | 3045 |
|